Učitavanje...
Drug-placebo additivity in randomized clinical trials
In randomized clinical trials (RCTs), it is assumed that non-specific effects beyond action of pharmacological agents are roughly equivalent in drug and placebo treatment groups. Hence, since the inception of RCTs, drug efficacy is determined by comparing outcomes in active to those in placebo contr...
Spremljeno u:
| Izdano u: | Clin Pharmacol Ther |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7168700/ https://ncbi.nlm.nih.gov/pubmed/31502253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1626 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|